Terex (TEX) Q1 2026 Earnings Transcript

Terex posted Q1 revenue of $1.7 billion, up 41% reported and 10.8% pro forma, with EPS rising 18% to $0.98 and backlog expanding to a record $7.1 billion. Management reiterated full-year 2026 guidance for 5% pro forma sales growth to $7.5 billion-$8.1 billion and EBITDA of $930 million-$1.0 billion, while highlighting $28 million of 2026 REV merger synergies on track toward a $75 million run-rate target. Margins were mixed, with Q1 EBITDA margin down 50 bps to 9.9% due mainly to tariffs, but bookings and segment outlooks remained strong across Materials Processing, Environmental Solutions, and Specialty Vehicles.

Analysis

The market is likely underestimating how much of Terex’s current earnings power is now self-help rather than cyclical beta. The REV combination is doing two things at once: pulling forward mix improvement into a higher-margin specialty platform while also de-risking the cash profile through better working capital density, which means incremental revenue is likely to convert to cash faster than consensus models assume. That creates a subtle but important setup where even modest demand upside can show up as disproportionately stronger deleveraging and repurchases later in the year.

The bigger second-order effect is competitive: Terex is using supply-chain localization and capacity adds to shorten lead times just as many peers remain bottlenecked. In capital equipment, lead-time compression often matters more than nominal pricing because it shifts dealer allocation and becomes sticky share gain; once customers spec a vendor into fleet replacement cycles, share losses are hard to win back. That suggests the real beneficiaries are Terex’s U.S.-centric product lines, while smaller regional competitors and import-reliant players are more exposed to tariff friction and freight inflation.

The contrarian angle is that guidance conservatism may be masking a more favorable earnings path, especially if backlog converts normally and the Aerials trough is already past. The main risk is that bookings strength in specialty vehicles and materials processing is partially timing-driven; if dealer restocking and customer prebuys normalize faster than expected, 2027 growth could look less dramatic even if 2026 prints well. In other words, the stock’s near-term rerating is about execution certainty, not just peak-cycle optimism.

The key catalyst window is the next two quarters: Q2 should validate margin phasing, and Q3 should show whether backlog actually converts into higher throughput without unexpected price/cost leakage. If that happens, leverage should grind lower fast enough to reopen capital return optionality, which is the most underappreciated re-rating lever here.

Key Decisions for Investors

• Long TEX vs. industrials basket (XLI) for 3-6 months: thesis is self-help + backlog conversion + deleveraging; risk/reward improves if Q2/Q3 margins expand as guided and the stock rerates on cash conversion.
• Pair trade long TEX / short REVG over the next 1-2 quarters: Terex has the better balance sheet, broader demand visibility, and lower integration execution risk; downside is if REV-specific synergies surprise faster than expected.
• Buy TEX on weakness into any post-earnings consolidation, targeting a 6-9 month horizon: use a staged entry because the setup is more about confirmation of backlog conversion than a single-quarter beat.
• Consider a call spread in TEX into Q2 results (3-4 month tenor): upside comes from margin phasing and leverage reduction; risk is guidance stays unchanged and the market treats current execution as already priced in.
• If looking for a hedge, short small-cap cyclical equipment names with higher import exposure and weaker lead times versus TEX: tariff and freight pressure should widen the operating gap over the next 2-3 quarters.